Article
Trial Readiness: Understanding the Natural History of Rare Diseases.
Journal of inherited metabolic disease - 1 Nov 2025
Opladen Thomas, Mütze Ulrike, Gleich Florian, Garbade Sven F, Kuseyri Hübschmann Oya, Zielonka Matthias, Kölker Stefan
Abstract excerpt
Inherited metabolic diseases (IMD) represent the largest and still growing group of treatable genetic disorders and are increasingly amenable to targeted interventions that achieve varying degrees of prognostic improvement. Innovative therapies are on the horizon and offer promising opportunities for disease-changing treatment for a variety of IMDs. For the development of clinical trials specifically for IMDs and...
Read the complete abstract on PubMedTopics
- Humans
- Rare Diseases
- Clinical Trials as Topic
- Registries
- Metabolic Diseases
- Quality of Life
